GSE110709 GSK-J4 5 v 4 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE110709_GSK-J4_5_v_4_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE110709_GSK-J4_5_v_4_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE110709_GSK-J4_5_v_4_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE110709_GSK-J4_5_v_4_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

acetylserotonin O-methyltransferase like

Gene

vesicle associated membrane protein 7

Gene

A-kinase anchoring protein 17A

Gene

Pvt1 oncogene

Gene

long intergenic non-protein coding RNA 665

Gene

long intergenic non-protein coding RNA 511

Gene

FGD5 antisense RNA 1

Gene

protein kinase Y-linked (pseudogene)

Gene

lung cancer associated transcript 1

Gene

zinc finger protein 542, pseudogene

  • Gene

    acetylserotonin O-methyltransferase like


  • Gene

    vesicle associated membrane protein 7


  • Gene

    A-kinase anchoring protein 17A



  • Gene

    long intergenic non-protein coding RNA 665


  • Gene

    long intergenic non-protein coding RNA 511


  • Gene

    FGD5 antisense RNA 1


  • Gene

    protein kinase Y-linked (pseudogene)


  • Gene

    lung cancer associated transcript 1


  • Gene

    zinc finger protein 542, pseudogene

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.